A B S T R A C T We investigated the effect of elastaselike neutral protease isolated from human granulocytes on human fibrinogen. Dependent on enzyme concentration and time of incubation, the elastase-like protease induced a progressive degradation of fibrinogen. Analysis of the remaining polypeptide chains showed a high susceptibility of the Aa-and low susceptibility of the y-chain of fibrinogen towards the proteolytic action of the enzyme. The split products were characterized by polyacrylamide gel electrophoresis and two-dimensional immunoelectrophoresis. They showed antigenic determinants of fibrinogen and of plasmin-induced proteolysis products D and E. The cleavage fragments isolated by gel chromatography had distinct molecular weights. Coagulability of fibrinogen by thrombin was inhibited according to the concentration of the protease and the time of incubation. Split products of fibrinogen with higher molecular weight prolonged the coagulation time of native fibrinogen, whereas low molecular weight fragments were ineffective.
INTRODUCTION
The ability of leukocyte enzymes to degrade fibrin at neutral or slightly alkaline pH was first demonstrated by Rulot (1) and Opie (2) . Further studies indicated that both fibrinogen and fibrin are susceptible to the action of leukocyte enzymes (3) (4) (5) and that the intrinsic enzymatic system of the leukocytes is distinct from plasmin (6) (7) (8) (9) (10) . Apparently, intracellular plasminogen does not account for fibrinolysis, as only very low plasminogen levels have been detected in polymorphonuclear leukocytes (8, 11, 12) .
Recently, Ohlsson and Olsson (9) , Ohlsson (13) , and
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Schmidt et al. (14) (15) (16) (17) showed that human polymorphonuclear granulocytes contain two neutral proteases capable of degrading fibrinogen. A chymotrypsin-like protease, which predominantly hydrolyses peptide bonds adjacent to the carboxyl group of phenylalanine, exhibited only a weak reactivity with
fibrinogen. An elastase-like protease (ELP),1 which preferentially acts on peptide bonds with valine and alanine as the carboxyl group donor, showed strong activity with fibrinogen comparable to that of trypsin (16, 17) .
More detailed studies on fibrinolysis by leukocyte proteases have been performed only with crude leukocyte extracts (10, 12) . The fibrinogen degradation products formed by the leukocyte extracts were found to be completely different from those generated by plasmin.
Our studies with purified human granulocyte elastase, however, show a similarity between the plasminproduced D and E fragments and the proteolysis products of degradation by ELP. Until now, the process of fibrinogen degradation by leukocytes has been mainly considered to involve the release of thromboplastic substances from leukocytes, triggering the formation of thrombin. This would result in consumption of clotting factors and subsequent activation of circulating plasminogen, followed by the appearance of D and E fragments (18) (19) (20) . The detection of D and E split products in the bloodstream is therefore regarded as a major indicator for the clinical syndrome of intravascular coagulation (18, 19) . The results given below suggest that the appearance of D and E fragments is not necessarily a specific marker for plasmin fibrinolysis.
Other mechanisms, e.g. direct fibrinogenolysis by ' Abbreviations used in this paper: ELP, elastase-like protease; Fbg, fibrinogen; SDS, sodium dodecyl sulfate. ELP, may be equally responsible for the production of D and E fragments. This study, investigates in detail the ability of purified human ELP to degrade human fibrinogen. The resulting split products were characterized with respect to their antigenic determinants, which were compared with those of native fibrinogen and plasmin split products. The ability of fibrinogen fragments to influence blood coagulation in vitro was also investigated. ELP was isolated from extracts of granules of polymorphonuclear leukocytes as published previously (15) . The purity of the enzyme was at least 96% (17) . The Coagulability of Fbg after incubation with ELP. Fbg (2 mg/ml) was incubated with 0.1 vol of increasing concentrations of ELP (0.035-0.35 ,ug/mg Fbg) at 37°C for various periods of time, ranging from 5 min to 24 h. At the indicated intervals 0.1-ml aliquots of the reaction mixture were removed and incubated with 0.2 ml thrombin (0.3 NIH/ml) and the coagulation time was measured. 0.1 ml Fbg (2 mg/ml) plus 0.2 ml thrombin (0.3 NIH/ml) served as a control.
METHODS
Anticoagulant activity ofELP-generated Fbg split products was tested in the following manner: Fbg was incubated with 0.1 vol ELP as described above. After 5 and 10 min of incubation at 37°C, 50 ,ug a,-antitrypsin/mg ELP was added. 0.1 ml of Fbg (2 mg/ml), 0.1 ml of this incubation mixture, and 0.1 ml of thrombin (1.2 NIH U/ml) were mixed and the clotting time was measured. Controls were either 0.1 ml Fbg, 0.1 ml buffer, and 0.1 ml thrombin, or 0.2 ml Fbg and 0.1 ml thrombin.
RESULTS
During the action of purified ELP on human Fbg, a number of high and low molecular weight split products were produced depending on enzyme concentration and time of incubation. Fig. 1 shows a SDS-polyacrylamide gel electrophoresis of unreduced Fbg which was incubated with different concentrations of ELP (gels 2-5) and plasmin (gels 6-9) for 1 h (ELP left part, plasmin right part of the figure). During fibrinolysis with different plasmin concentrations, almost identical fragments resulted, whereas increasing amounts of ELP induced a progressive fibrinolysis to a fragment somewhat larger (mol wt = 300,000) than fragment X (mol wt= 270,000). This was followed by rapid cleavage into a number of smaller fragments at higher enzyme concentrations. At an ELP concentration of 5 ,g/mg Fbg, one line corresponding in molecuilar weight to fragment Y (mol wt = 140,000) was observed. An additional protein band with a mol wt 40,000, similar to fragment E, was visible in this gel. This fragment also appeared at the highest ELP concentration used (20 gg/ml Fbg). The largest proteolysis product arising at this enzyme concentration corresponded in molecular weight to the plasmininduced fragment D. SDS-polyacrylamide gel electrophoresis of a 24-h incubation (not shown) demonstrated an increase of proteolysis with increasing ELP concentrations, whereas the pattern of plasmin fibrinogenolysis remained constant at different plasmin concentrations.
In To characterize the degradation products generated by ELP immunologically, two-dimensional immunoelectrophoresis was performed. Fig. 3 demonstrates a series of two-dimensional immunoelectrophoreses with aiiti-Fbg serum in the second dimension. Fbg was incubated with 0.3, 1.2, and 5.0 ,ug ELP/mg Fbg for 10 min, and 1 and 4 h. One to six precipitation arcs were formed depending on the incubation time and the ELP concentration. Each represents a fragment with antigenic determinants of Fbg. A similar but not jdentical pattern was observed with 20 ,ug ELP/mg Fbg (not shown), indicating progressive proteolysis. To exclude the loss of very fast migrating split products, the length of the first dimension was doubled. Additional precipitation lines were not detected (not shown).
As described above, in proteolysis of Fbg by ELP, some fragments were obtained which were similar in molecular weight to those generated by plasmin. Two-dimensional immunoelectrophoresis using anti-D and anti-E serum showed that fragments sharing antigenic determinants of the plasmin-induced D and E fragments appeared at certain stages of ELP degradation. Two-dimensional immunoelectrophoresis of an ELP Fbg incubation mixture (5 ,ug ELP/mg Fbg, 1 h) with anti-Fbg, anti-D, and anti-E serum is shown in Fig. 4. Fig. 4A shows the reaction of the degraded Fbg with anti-Fbg serum. As already shown in Fig. 3 (Fig. 4C) . To separate the D-and E-like fragments, the ELP Fbg incubation mixture (5 ,g ELP/mg Fbg, 1 h) was applied to a gel chromatography column (Bio-Gel A 1.5 m). Single fractions were obtained that reacted either with anti-D or anti-E serum, as shown by countercurrent electrophoresis (Fig. 5) . D-and E-like fragments were also isolated by DEAE chromatography FIGURE 4 Two-dimensional immunoelectrophoresis of using a decreasing sodium and an increasing potassium It was of interest to know how the enzyme affects (Fig. 4B) . With anti-E serum a pattern similar to that ob-the thrombin coagulation of Fbg. The experiments served with anti-Fbg serum resulted (Fig. 4C) . The two showed that the clotting of Fbg was inhibited dependarcs at the position of native Fbg were, however, missing. ing on the incubation time and the enzyme concenThe fast migrating peak, which had the same position tration. as the control E below, only became visible with antiFbg became uncoagulable after a 10-min incubation (4, 24, 25) . This concentration of cells may be facilif the native Fbg was observed in SDS-tated by chemotactic agents including chemotactic le gel electrophoresis and in two-di-fibrinopeptides (25) . Once localized, active release of mmunoelectrophoresis under similar proteolytic enzymes from the granulocytes may be 'he coagulation time of Fbg therefore, induced by various mechanisms. Fibrinolysis proceeds isitive method for determining Fbg de-at neutral pH, where most cathepsins are inactive ELP. (3, 16, 26, 27) . In this respect, the neutral granulocyte anticoagulant activity of the Fbg frag-protease ELP may be of particular importance: ELP ed after a 5-and 10-min incubation with is actively secreted during frustrated phagocytosis on centrations of ELP was tested (Fig. 6) . nonphagocytable surfaces, in the presence of antigenstage of degradation (1.5 and 1.75 ,ug antibody complexes, complement components, and in ), split products were formed that com-the presence of endotoxin, whereas the chymotrypsinited the coagulation of Fbg. These split like protease remains within the cells (28, 29) . ld not be coagulated independently.
In two recent studies, Bilezikian and Nossel (10) and higher thrombin concentrations to the Plow and Edgington (12) investigated the effect of samples resulted in clotting again. As leukocyte extract on Fbg (10, 12) . The leukocyte exby the abrupt decrease of the curves, tract caused a rapid cleavage of all three primary dation led to fragments which no longer constituent chains of fibrinogen including the y-chain. th Fbg coagulation.
The ability of the extract to attack the y-chain of Fbg primarily and rapidly was used to distinguish the 12-17. was rapidly destroyed by ELP. In contrast, the B,8-)nuclear granulocytes frequently ac-and the y-chain appeared to be little affected, whereas incubation with crude extracts resulted in degradation of these subunits. Only at higher ELP concentrations >f >u was the B,f-and then the y-chain fully degraded. The band observed at mol wt = 300,000 in SDS-polyacrylamide gel electrophoresis under unreduced conditions, was similar to that reported by Bilezikian and Nossel (10) and Plow and Edgington (12) . The different specificity of the leukocyte extract may be due to the presence of other intracellular proteases. Possibly only the ELP is of major importance in extracellular proteolysis of Fbg, since it is the only protease to be actively secreted. As demonstrated in SDS-polyacrylamide gel electrophoresis (Fig. 1 (14, 22, 30) . This is supported by studies showing a correlation between circulating ELP and coagulation defects in patients with acute leukemia and septicemia (22) . In addition, intravenous injection of ELP in green monkeys induced a marked drop in several coagulation factors including Fbg, and produced an increase in Fbg degradation products and severe bleeding complications (30) .
The appearance of Fbg fragments sharing antigenic determinants with the plasmin-derived proteolysis products in these patients and in the animal experiment may therefore be due to a direct proteolysis of ELP rather than plasmin fibrinolysis. A number of clinical syndromes may therefore represent ELPinduced clotting factor deficiencies, which would require special treatment.
